Julie Kerner
Senior Vice President of Business OperationsDr. Julie Kerner, Ph. D., is Senior Vice President of Business Operations of Neuphoria Therapeutics Inc. (formerly known as Bionomics Limited) from May 2023. She has experience where under her leadership companies created portfolio and platform strategies, built new therapeutic areas, filed over 10 IND/CTAs, conducted proof of concept and Phase 3 trials, and launched multiple therapeutics. Most recently, she worked at Fulcrum Therapeutics and Aliada Therapeutics driving pipeline strategy and program leadership. Prior to that, she worked at AVROBIO, Wave Life Sciences, and Biogen working across R&D, Marketing, and early product planning. Before she joined industry, she earned a PhD in Neuroscience at Tufts Medical School and was a market Analyst at Decision Resources, writing over 10 reports on neurodegeneration, psychology, and pain. She is committed to patient centricity and advocacy, sitting on the boards of Newton Wellesley Hospital, National Braille Press, and the US Neuroacanthocytosis advocacy, Inc.
Positions
- Company NameNeuphoria Therapeutics Inc.Stock CodeNEUPPositionSenior Vice President of Business OperationsColleagues
- SPSpyridon PapapetropoulosInterim CEO & Executive Director
- ADAlan David FisherIndependent Non-Executive Chair of the Board
- TMTimothy M. CunninghamFractional CFO
- AHAdrian HintonFinancial Controller
- RCRajeev ChandraCompany Secretary
- JRJane RyanIndependent Non-Executive Director
- DIDavid Ian WilsonIndependent Non-Executive Director
- MBMurray B. SteinMember of Clinical Advisory Board
